Most cost-effective method to monitor ART in adults in Africa?

January 2014
PharmacoEconomics & Outcomes News;Jan2014, Issue 694, p6
The article discusses research being done on the cost-effectiveness of different strategies for monitoring adults on antiretroviral treatment, which references a study by D. Keebler et al. published in the December 10, 2013 issue of "The Lancet Global Health."


Related Articles

  • Earlier eligibility for ART good value for money.  // PharmacoEconomics & Outcomes News;Jan2014, Issue 694, p5 

    The article discusses research being done on the health benefits and cost-effectiveness of earlier eligibility for antiretroviral therapy, which references a study by J. W. Eaton et al. published in the December 10, 2013 issue of "The Lancet Global Health."

  • ART for Life's Sake: The Profound affect of Antiretroviral Therapy on H IV in Africa. Winslow, Dean L. // Infectious Disease Alert;Feb2014, Vol. 33 Issue 5, p49 

    Survival benefits in adults attributable to antiretroviral therapy (ART) initiated in South Africa since 2004 were quantified using the Cost-Effectiveness of Preventing AIDS Complications-International model (CEPAC) simulating 8 cohorts of HIV-infected patients initiating therapy each year...

  • ART cost for kids in South Africa.  // PharmacoEconomics & Outcomes News;10/13/2012, Issue 664, p7 

    The article discusses research on the cost and outcomes of paediatric antiretroviral treatment in South Africa, referencing a study by G. Meyer-Rat and colleagues, published in the September 25, 2012 issue of "AIDS."

  • Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa. Alistar, Sabina S.; Grant, Philip M.; Bendavid, Eran // BMC Medicine;2014, Vol. 12 Issue 1, p1 

    Background: Antiretroviral therapy (ART) and oral pre-exposure prophylaxis (PrEP) are effective in reducing HIV transmission in heterosexual adults. The epidemiologic impact and cost-effectiveness of combined prevention approaches in resource-limited settings remain unclear. Methods: We develop...

  • The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States. Shah, Maunank; Risher, Kathryn; Berry, Stephen A.; Dowdy, David W. // Clinical Infectious Diseases;1/15/2016, Vol. 62 Issue 2, p220 

    Background: Recent guidelines advocate early antiretroviral therapy (ART) to decrease human immunodeficiency virus (HIV) morbidity and prevent transmission, but suboptimal engagement in care may compromise impact. We sought to determine the economic and epidemiologic impact of incomplete...

  • Patients Lost to Care Are More Likely to be Viremic Than Patients Still in Care. Stinson, Kathryn; Ford, Nathan; Cox, Vivian; Boulle, Andrew // Clinical Infectious Diseases;May2014, Vol. 58 Issue 9, p1344 

    A letter to the editor is presented which discusses virological failure among patients on first-line antiretroviral therapy (ART) in Sub-Saharan Africa and Southeast Asia.

  • Corrigendum.  // Journal of the International AIDS Society;2013, Vol. 16 Issue 1, p1 

    A correction to the article "Individual and contextual factors influencing patient attrition from antiretroviral therapy care in an urban community of Lusaka, Zambia" is presented.

  • The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy. Ross, Eric L.; Weinstein, Milton C.; Schackman, Bruce R.; Sax, Paul E.; Paltiel, A. David; Walensky, Rochelle P.; Freedberg, Kenneth A.; Losina, Elena // Clinical Infectious Diseases;Apr2015, Vol. 60 Issue 7, p1102 

    Background. Long-acting antiretroviral therapy (LA-ART) is currently under development and could improve outcomes for human immunodeficiency virus (HIV)-infected individuals with poor daily ART adherence. Methods. We used a computer simulation model to evaluate the cost-effectiveness of 3 LA-ART...

  • Diplopia in a Patient with HIV Infection. Dhillon, Wishwdeep S.; Shah, Tushar // New England Journal of Medicine;4/15/2010, Vol. 362 Issue 15, pe52 

    The article presents a case study of a man with human immunodeficiency virus (HIV) infection who was receiving highly active antiretroviral therapy and found to have diplopia and headache for a week.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics